Filter
482
Filtered Results: 482
Text search:
vials
Featured
Recommendations
78
New Publications
128
Language
Document type
No document type
225
Guidelines
122
Studies & Reports
43
Manuals
37
Fact sheets
21
Training Material
11
Infographics
10
Strategic & Response Plan
9
Situation Updates
3
Resource Platforms
1
Countries / Regions
India
57
Kenya
15
Ethiopia
14
Global
13
South Africa
11
Nigeria
9
Nepal
9
Zambia
9
Africa
9
Uganda
8
Philippines
8
Sierra Leone
7
Rwanda
7
Liberia
5
Ghana
5
Tanzania
5
Malawi
5
Latin America and the Carribbean
5
Congo, Democratic Republic of
4
Haiti
4
Pakistan
4
Syria
4
Zimbabwe
3
Argentina
3
Namibia
3
Eswatini/ Swaziland
3
Ukraine
3
West and Central Africa
3
Middle East and North Africa
3
Lebanon
2
Sudan
2
Botswana
2
Angola
2
Madagascar
2
Myanmar / Burma
2
Yemen
2
East and Southern Africa
2
Western and Central Europe
2
Russia
2
Guinea-Bissau
1
Morocco
1
Saudi Arabia
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Germany
1
Cambodia
1
Indonesia
1
Bangladesh
1
Mozambique
1
Central African Republic
1
Brazil
1
Greece
1
Libya
1
South–East Asia Region
1
Asia
1
Bhutan
1
Eastern Europe
1
Albania
1
Iran
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
191
Clinical Guidelines
83
Key Resources
33
Women & Child Health
27
Public Health
22
Pharmacy & Technologies
15
Capacity Building
13
Toolboxes
COVID-19
72
Pharmacy
56
Ebola
27
Rapid Response
23
NTDs
23
Caregiver
22
TB
17
AMR
17
Polio
14
HIV
10
Conflict
7
Cholera
6
NCDs
6
Planetary Health
5
Natural Hazards
4
Refugee
3
Disability
1
Zika
1
Mental Health
1
Specific Hazards
1
Health Financing Toolbox
1
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
While epidemiological data for type 1 diabetes (T1D) in low/middle-income countries, and particularly low-income countries (LICs) including Liberia is lacking, prevalence in LICs is thought to be increasing. T1D care in LICs is often impacted by challenges in diagnosis and management. These challeng...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
A erradicação da varíola humana (mpox em inglês) foi certificada em 1980. A varíola símia (mpox em inglês) é endêmica nos países da África Central e Ocidental desde a sua primeira detecção, em 1958. Trata-se de uma zoonose cujos casos geralmente ocorrem perto de florestas tropicais, ond...
El 23 de julio del 2022, el Director General de la OMS declaró el brote de viruela símica una emergencia de salud pública de importancia internacional. A raíz de esa declaración, se puso en marcha un dispositivo de respuesta coordinada con el objeto de interrumpir la transmisión y proteger a l...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
Operational Guideline
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive health medicines. The list is intended to support decisions regarding the production, quality assurance...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,...
Guidance for health workers
GUIDELINES FOR AWWs/ASHAs/ANMs/PRIs
6th edition
Accessed July 2014.
Information and Approaches for developing Country Settings
